Clinical Trials Browser

Phase 4 × Recruiting × Genitourinary × Clear all

NCT07474519 2026-03-16

Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer

Phase 4 Recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT06862219 2026-03-06

A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer

Phase 4 Recruiting

Carcinoma, Transitional Cell

NCT06764095 2026-02-12

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

Phase 4 Recruiting

Urinary Bladder Neoplasms, Ureteral Neoplasms

NCT07252726 2026-02-09

Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

Phase 4 Recruiting

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

NCT05348876 2026-01-30

A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)

Phase 4 Recruiting

Prostatic Neoplasms

NCT04373564 2026-01-22

ODYSSEY

Phase 4 Recruiting

BreastEndocrineGastrointestinalGenitourinaryNET

Breast Neoplasms, Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

NCT05962541 2025-12-31

CUT-less

Phase 4 Recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT05919329 2025-10-24

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Phase 4 Recruiting

Castration Resistant Prostate Cancer

NCT06226129 2025-10-20

Gadopiclenol in Contrast Enhanced MRI of the Prostate

Phase 4 Recruiting

Prostatic Neoplasms

NCT07028125 2025-10-07

CANIQOL

Phase 4 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

NCT06781879 2025-10-03

COBRA-NMIBC

Phase 4 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT06934057 2025-09-24

CABOLD

Phase 4 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04532606 2025-07-30

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Phase 4 Recruiting

Emergence Delirium, Urinary Bladder Neoplasms, Delirium

NCT06908694 2025-07-29

GAINPCCONTROL

Phase 4 Recruiting

Prostatic Neoplasms

NCT06903312 2025-07-03

ITALIC-RCC

Phase 4 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07001709 2025-06-03

ENABLE

Phase 4 Recruiting

Cancer Pain, Prostatic Neoplasms

NCT05805436 2025-05-30

Preop Laxatives in Robotic Urologic Surgery

Phase 4 Recruiting

GenitourinaryOther

Constipation, Kidney Neoplasms, Prostatic Neoplasms

NCT05803941 2025-04-24

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Phase 4 Recruiting

Prostatic Neoplasms

NCT06875258 2025-03-13

PEHAB-II

Phase 4 Recruiting

Erectile Dysfunction Following Radical Prostatectomy

NCT06709196 2025-01-09

REINFORCE

Phase 4 Recruiting

Cystectomy

NCT06706921 2024-11-27

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

Phase 4 Recruiting

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant

NCT05629494 2024-10-18

ADAPT-PSA

Phase 4 Recruiting

Prostatic Neoplasms, Prostatitis

NCT06215976 2024-08-20

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

Phase 4 Recruiting

Urinary Bladder Neoplasms

NCT05957822 2024-05-14

Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery

Phase 4 Recruiting

GastrointestinalGenitourinary

Hemorrhage, Liver Neoplasms, Prostatic Neoplasms, Seizures, Thromboembolism

NCT06001619 2023-08-21

PROMED

Phase 4 Recruiting

Prostatic Hyperplasia, Prostatic Neoplasms